Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Sean Maduck, See Remarks of Corcept Therapeutics Inc, sold 25,000 shares of common stock on October 1, 2026.
Summary
- Option exercise/conversion: acquired 413 Common Stock at $8.27 ($3,416) on October 1, 2026; holds 10,351 after (Direct).
- Open-market sale: disposed of 413 Common Stock at $115.54 ($47,717) on October 1, 2026; holds 9,938 after (Direct).
- Option exercise/conversion: acquired 24,587 Common Stock at $8.27 ($203,334) on October 2, 2026; holds 34,525 after (Direct).
- Open-market sale: disposed of 15,843 Common Stock at $116.12 ($1,839,741) on October 2, 2026; holds 18,682 after (Direct).
- Open-market sale: disposed of 8,744 Common Stock at $116.55 ($1,019,143) on October 2, 2026; holds 9,938 after (Direct).
- Option exercise/conversion: disposed of 413 Stock option (right to buy) on October 1, 2026; holds 66,573 after (Direct).
- Option exercise/conversion: disposed of 24,587 Stock option (right to buy) on October 2, 2026; holds 41,986 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,906,601 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Sean Maduck — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 413 | $8 | $3.4K | 10,351 |
| 2026-10-01 | Open-market sale | Common Stock | 413 | $116 | $47.7K | 9,938 |
| 2026-10-02 | Option exercise/conversion | Common Stock | 24,587 | $8 | $203.3K | 34,525 |
| 2026-10-02 | Open-market sale | Common Stock | 15,843 | $116 | $1.8M | 18,682 |
| 2026-10-02 | Open-market sale | Common Stock | 8,744 | $117 | $1.0M | 9,938 |
| 2026-10-01 | Option exercise/conversion | Stock option (right to buy) | 413 | — | — | 66,573 |
| 2026-10-02 | Option exercise/conversion | Stock option (right to buy) | 24,587 | — | — | 41,986 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (413 shares) |
| 2026-10-01 | Open-market sale (413 shares) |
| 2026-10-02 | Option exercise/conversion (24,587 shares) |
| 2026-10-02 | Open-market sale (15,843 shares) |
| 2026-10-02 | Open-market sale (8,744 shares) |
| 2026-10-01 | Option exercise/conversion (413 shares) |
| 2026-10-02 | Option exercise/conversion (24,587 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Sean Maduck
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.